These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors]. Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549 [No Abstract] [Full Text] [Related]
5. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer. Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794 [TBL] [Abstract][Full Text] [Related]
6. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Glynne-Jones R; Mawdsley S; Novell JR Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329 [TBL] [Abstract][Full Text] [Related]
7. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. Nilsson PJ; van Etten B; Hospers GA; Påhlman L; van de Velde CJ; Beets-Tan RG; Blomqvist L; Beukema JC; Kapiteijn E; Marijnen CA; Nagtegaal ID; Wiggers T; Glimelius B BMC Cancer; 2013 Jun; 13():279. PubMed ID: 23742033 [TBL] [Abstract][Full Text] [Related]
8. Total neoadjuvant therapy for rectal cancer: An emerging option. Ludmir EB; Palta M; Willett CG; Czito BG Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220 [TBL] [Abstract][Full Text] [Related]
9. [Rectal cancer: Towards personalized medicine]. Vendrely V; Benoist S Cancer Radiother; 2021 Oct; 25(6-7):650-654. PubMed ID: 34266737 [TBL] [Abstract][Full Text] [Related]
10. Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome. Hess V; Winterhalder R; von Moos R; Widmer L; Stocker P; Jermann M; Herrmann R; Koeberle D Clin Colorectal Cancer; 2017 Sep; 16(3):240-245. PubMed ID: 27687815 [TBL] [Abstract][Full Text] [Related]
11. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series. Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572 [TBL] [Abstract][Full Text] [Related]
12. The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer. Bhudia J; Glynne-Jones R Curr Treat Options Oncol; 2022 Apr; 23(4):453-473. PubMed ID: 35312962 [TBL] [Abstract][Full Text] [Related]
13. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer. Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509 [TBL] [Abstract][Full Text] [Related]
14. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer. Gollins S Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363 [TBL] [Abstract][Full Text] [Related]
15. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis. Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162 [TBL] [Abstract][Full Text] [Related]
16. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
17. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. Gollins S; West N; Sebag-Montefiore D; Susnerwala S; Falk S; Brown N; Saunders M; Quirke P; Ray R; Parsons P; Griffiths G; Maughan T; Adams R; Hurt C Br J Cancer; 2018 Sep; 119(6):697-706. PubMed ID: 30116024 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
19. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419 [TBL] [Abstract][Full Text] [Related]